Thompson Investment Management, Inc. Abbott Laboratories Transaction History

Thompson Investment Management, Inc.

$626 Million
Q2 2024

A detailed history of Thompson Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 1,788 shares of ABT stock, worth $203,849. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,788

Previous 8,963 80.05%

Holding current value

$203,849

Previous $1.02 Million 81.83%

% of portfolio

0.03%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	SELL	$100.73 - $112.44 $722,737 - $806,757	-7,175 Reduced 80.05%	1,788 $185,000
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $68,997 - $76,204	-630 Reduced 6.57%	8,963 $1.02 Million
Q4 2023 Jan 16, 2024	SELL	$90.19 - $110.4 $7,125 - $8,721	-79 Reduced 0.82%	9,593 $1.06 Million
Q2 2023 Jul 10, 2023	BUY	$100.78 - $112.29 $50,289 - $56,032	499 Added 5.44%	9,672 $1.05 Million
Q1 2023 Apr 24, 2023	BUY	$96.86 - $114.01 $67,898 - $79,921	701 Added 8.27%	9,173 $928,000
Q3 2022 Oct 17, 2022	SELL	$96.76 - $112.03 $27,092 - $31,368	-280 Reduced 3.2%	8,472 $820,000
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $172,192 - $208,125	-1,687 Reduced 16.16%	8,752 $951,000
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $19,839 - $24,192	-174 Reduced 1.64%	10,439 $1.24 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $115 - $141	1 Added 0.01%	10,613 $1.49 Million
Q3 2021 Oct 13, 2021	SELL	$116.66 - $129.06 $349,980 - $387,180	-3,000 Reduced 22.04%	10,612 $1.25 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $402,002 - $473,214	3,800 Added 38.73%	13,612 $1.58 Million
Q1 2021 Apr 07, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.01%	9,812 $1.18 Million
Q4 2020 Jan 19, 2021	SELL	$105.0 - $114.42 $43,050 - $46,912	-410 Reduced 4.01%	9,811 $1.07 Million
Q3 2020 Oct 13, 2020	BUY	$91.64 - $111.29 $91 - $111	1 Added 0.01%	10,221 $1.11 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $452,241 - $661,300	-7,199 Reduced 41.33%	10,220 $806,000
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $89,972 - $100,160	1,146 Added 7.04%	17,419 $1.51 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $128,898 - $139,765	-1,575 Reduced 8.82%	16,273 $1.36 Million
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $238,127 - $287,895	-3,596 Reduced 16.77%	17,848 $1.43 Million
Q4 2018 Feb 04, 2019	SELL	$65.56 - $74.27 $110,861 - $125,590	-1,691 Reduced 7.31%	21,444 $1.55 Million
Q2 2018 Jul 09, 2018	SELL	$57.57 - $63.54 $74,092 - $81,775	-1,287 Reduced 5.27%	23,135 $1.41 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $1.37 Million - $1.55 Million	24,422 New	24,422 $1.46 Million

Others Institutions Holding ABT

# of Institutions

3,136

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Investment Management, Inc. with notifications on news.

Account

Thompson Investment Management, Inc. Abbott Laboratories Transaction History